Dr. DeAngelo's current research interests include novel immunotherapeutic approaches to the treatment of acute myelogenous leukemia and myelodysplasia. He is currently developing leukemia tumor vaccines from patients with AML or advanced myelodysplasia and will be assaying for immunological and serological responses.
Dana Farber Cancer Institute:
450 Brookline Ave, Boston, MA 02215, USA
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: